We demonstrated that prolonged treatment of CDK4/6i upregulates GLS1 expression in BrafV600E melanoma cells, which may reflect recent studies demonstrating that CDK4/6i reprograms mitochondrial metabolism [35, 36]. Here, CDK4 is linked to melanoma.